person · Reporting owner
Gabai-Pinsky Veronique
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bath & Body Works, Inc.BBWI · Entity 4091 | Chief Brand & Product Officer | June 11, 2026 | June 15, 2026 |
| INTERPARFUMS INCIPAR · Entity 4092 | Director | August 27, 2026 | August 27, 2026 |
| LIFETIME BRANDS, INCLCUT · Entity 671 | Director | June 18, 2025 | June 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bath & Body Works, Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 27,594 |
Reported balance
Holding disclosure · report date 2026-06-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 27,594 F1: Annual grant of restricted stock units vesting 30% on the first anniversary of the grant date, 30% on the second anniversary of the grant date and 40% on the third anniversary of the grant date, granted June 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of restricted stock units vesting 30% on the first anniversary of the grant date, 30% on the second anniversary of the grant date and 40% on the third anniversary of the grant date, granted June 10, 2026.
INTERPARFUMS INC
Report date August 27, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 900 |
Reported balance
After 2026-08-27 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2026-08-27 · Exercise / conversion · Acquired 900 · Balance 900 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-27 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2026-08-27 · Sale · Disposed 900 · Balance 0 |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 0 |
Reported balance
After 2026-08-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-27 · Exercise / conversion · Disposed 300 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 0 |
Reported balance
After 2026-08-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-27 · Exercise / conversion · Disposed 300 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 0 |
Reported balance
After 2026-08-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-27 · Exercise / conversion · Disposed 300 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $147.71 · Expires 2029-12-28 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $130.60 · Expires 2030-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $84.64 · Expires 2031-12-30 | Direct | 300 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 300 |
LIFETIME BRANDS, INC
Report date June 18, 2025 · Filed June 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,654 |
Reported balance
After 2025-06-18 transaction · row 1
1 source rowRow 1 · 2025-06-18 · Grant · Acquired 27,777 · Balance 79,654 F1: The restricted stock was granted on June 18, 2025, pursuant to the Company's Amended and Restated 2000 Long-Term Incentive Plan (as amended through June 20, 2024) and vests on the first anniversary of the date of grant. F2: The common stock was issued for no consideration as part of director compensation. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 3,500 |
Reported balance
Holding disclosure · report date 2025-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,500 |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock was granted on June 18, 2025, pursuant to the Company's Amended and Restated 2000 Long-Term Incentive Plan (as amended through June 20, 2024) and vests on the first anniversary of the date of grant.
F2: The common stock was issued for no consideration as part of director compensation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 22, 2022 Filed Aug 23, 2022 22:46 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 500 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001124 · ownership.xml · derivative · entry 3 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:46 UTC | INTERPARFUMS INC IPAR · Entity 4092 | SaleCommon Stock | 2,000 | $82.42 | $164,843.20 |
DisclosureSEC source: 0001753926-22-001124 · ownership.xml · nonDerivative · entry 2 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:46 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 2,000 | $40.15 | $80,300.00 |
DisclosureSEC source: 0001753926-22-001124 · ownership.xml · nonDerivative · entry 1 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 20:57 UTC | LIFETIME BRANDS, INC LCUT · Entity 671 | GrantCommon Stock | 6,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-018092 · wf-form4_165636343687267.xml · nonDerivative · entry 1 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,871 F1 · shares: The restricted stock was granted on June 23, 2022, pursuant to the Company's Amended and Restated 2000 Long-Term Incentive Plan and vest on the first anniversary of the date of grant. F2 · price: The common stock was issued for no consideration as part of director compensation. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 21:22 UTC | LIFETIME BRANDS, INC LCUT · Entity 671 | GrantCommon Stock | 5,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012985 · wf-form4_162465612652899.xml · nonDerivative · entry 1 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,885 F1 · price: The common stock was issued for no consideration as part of director compensation. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:21 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006440 · ownership.xml · derivative · entry 16 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:21 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006440 · ownership.xml · derivative · entry 15 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:21 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006440 · ownership.xml · derivative · entry 14 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:21 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $62.18 | $0.00 |
DisclosureSEC source: 0001213900-21-006440 · ownership.xml · derivative · entry 13 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-01-31 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 20:55 UTC | LIFETIME BRANDS, INC LCUT · Entity 671 | GrantCommon Stock | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-010121 · wf-form4_159363685341566.xml · nonDerivative · entry 1 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417 F1 · price: The common stock was issued for no consideration as part of director compensation. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:06 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002540 · ownership.xml · derivative · entry 12 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:06 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002540 · ownership.xml · derivative · entry 11 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:06 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002540 · ownership.xml · derivative · entry 10 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 19:06 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002540 · ownership.xml · derivative · entry 9 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2025-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:57 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001833 · s115874_form4.xml · derivative · entry 8 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 500 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:57 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001833 · s115874_form4.xml · derivative · entry 7 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 500 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:57 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001833 · s115874_form4.xml · derivative · entry 6 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 500 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:57 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-001833 · s115874_form4.xml · derivative · entry 5 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 500 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 8, 2019 21:33 UTC Amendment | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-002153 · s115982_form4a.xml · derivative · entry 4 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 8, 2019 21:33 UTC Amendment | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-002153 · s115982_form4a.xml · derivative · entry 3 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 8, 2019 21:33 UTC Amendment | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-002153 · s115982_form4a.xml · derivative · entry 2 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
| February 01, 2019 Filed Feb 8, 2019 21:33 UTC Amendment | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $66.46 | $0.00 |
DisclosureSEC source: 0001615774-19-002153 · s115982_form4a.xml · derivative · entry 1 Gabai-Pinsky Veronique · CIK 0001714373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2024-01-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.